Pattern of Use of Anti-Hypertensive Drugs In a North Indian Tertiary Care Hospital Renu, Hema Chhabra, Anita Gupta, Neetu Sharma
|
|
- Diana Fletcher
- 5 years ago
- Views:
Transcription
1 Original Article Pattern of Use of Anti-Hypertensive Drugs In a North Indian Tertiary Care Hospital Renu, Hema Chhabra, Anita Gupta, Neetu Sharma Junior Resident, Professor and Head, Assistant ProfessorDepartment of Pharmacology, Government Medical College & Rajindra Hospital, Patiala, Punjab. ABSTRACT Background: Hypertension is a worldwide medical concern whose proper management forms the core of its control and prevention of its complications. Aims and objectives: To evaluate the prescribing patterns of anti-hypertensive drugs in the Cardiology department, Government medical college and Rajindra hospital, Patiala. Material and methods: It was a cross-sectional and observational study conducted over a period of 6 months. Results: During the study period, 192 prescriptions of hypertensive patients were analyzed. Among the anti-hypertensive drugs, 6 major classes were observed to be prescribed: Angiotensin receptor blockers (ARBs), beta blockers (BBs), calcium channel blockers (CCBs), diuretics (DUs), angiotensin converting enzyme inhibitors (ACEIs) and alpha blockers (ABs). Out of total 192 cases, 45 (23.4 %) received monotherapy, while 147 (76.6 %) received multi-drug therapy of antihypertensive agents. Angiotensin receptor blockers (ARBs) were the most commonly prescribed category both as monotherapy as well as in combination therapy. Two-drug combination was the most prevalent. Among two-drug therapy, ARBs + CCBs was the most commonly prescribed combination. Conclusion: ARBs were the most frequently prescribed anti-hypertensive category. Dual therapy was a part of majority of prescriptions ; ARBs + CCBs being the commonest combination. Keywords: Anti-hypertensive drugs, Hypertension, Prescription pattern, drug utilisation INTRODUCTION: ypertension is one of the major and i n d e p e n d e n t r i s k f a c t o r s f o r Hcardiovascular and cerebrovascular 1 events. According to the World Health Organization (WHO) global health observatory data 2016, it accounts for 12.8 % of the total deaths worldwide which is roughly 7.5 million people 2 across the globe. 3 blood pressure (DBP) 90 mmhg. The seventh report of the joint national committee (JNC 7) on prevention, detection, evaluation and treatment of high blood pressure (B.P.) classified hypertension 4 as follows: JNC 7 classification of hypertension[4] WHO defines hypertension as systolic blood pressure (SBP) 140 mmhg and/or diastolic Address for correspondence: Dr. Hema Chhabra, Junior Resident, Department of Pharmacology, Government Medical College, Patiala, Punjab, India. id: hemachhabra@rediffmail.com Ph. No.:
2 Dr. Hema Chhabra, et.al : Pattern of use of anti-hypertensive drugs Rational use of various anti-hypertensive drugs alone or in combination is the crux for proper health care management and improved quality of life of hypertensive patients. Purpose of the present study was to evaluate the drug utilization pattern of various anti-hypertensive agents in a routine clinical setting. MATERIAL AND METHODS: The present study was conducted over a period of six months (February July 2016) at Cardiology Out Patient Department (OPD), Government medical college and Rajindra hospital, Patiala. It was a cross-sectional and observational study. Patients with hypertension in stage I/stage II, newly diagnosed and old patients of hypertension and hypertensive patients with or without comorbidities were included in the study and pregnant patients with hypertension and patients with systolic BP > 210 and/or diastolic BP > 120 mm Hg, requiring emergency care were excluded. Their demographic and personal data: age, sex, diagnosis (stage of hypertension), h/o smoking and alcohol consumption were also collected. The prescriptions were evaluated. The study was approved by the Institutional Ethics Committee and written informed consent was taken from all the patients. Statistical analysis: The results of observations of individual patients were pooled and analyzed. The results were expressed as mean ± standard deviation and percentage as per applicability. Statistical analysis was performed using Statistical Program for Social Sciences (SPSS) software version 20.0 Chicago, Illinois, USA. RESULTS: In the present study, 192 prescriptions of hypertensive patients were evaluated over a period of six months. The mean age of presentation was found to be ± years. History of smoking was positive in 10 (8.7 %) patients and of alcohol in 4 (3.4 %) patients. Out of 192 cases, 100 (52 %) were males and 92 (48 %) were females. Majority of male patients were in the age range of years (33 %), while female preponderance was seen in the age range of years (35.87 %) (table 1). The mean systolic blood pressure (SBP) was ± mm Hg and mean diastolic blood pressure (DBP) was ± 7.78 mm Hg. The average number of drugs per prescription was 2.3 ± About 106 (55 %) patients were diagnosed with stage 1 and 86 (45 %) patients were diagnosed with stage 2 hypertension. Out of total 192 cases, 45 (23.4 %) received monotherapy, while 147 (76.6 %) received multidrug therapy of anti-hypertensive agents (table 2). Among monotherapy, the decreasing order of prescribing was as follows: Angiotensin receptor blockers (ARBs) 27 (60 %), calcium channel blockers (CCBs) 11 (24.4 %), diuretics (DUs) 4 (8.9 %) and angiotensin converting enzyme inhibitors (ACEIs) 3 (6.7 %) (figure 1). Beta blockers (BBs) and alpha blockers (ABs) were a part of combination therapy only. Two-drug combination was the most prevalent (table 2). Among two-drug therapy, ARBs + CCBs was the most commonly prescribed 21 (14.28 %) combination. Among three-drug therapy, ARBs + 183
3 Dr. Hema Chhabra, et.al : Pattern of use of anti-hypertensive drugs BBs + DUs was the most frequently prescribed 13 (8.84 %), while there was only one four-drug Table-2 : Monotherapy versus multi-drug therapy of anti-hypertensive drugs combination ARBs + BBs + CCBs + DUs in 7 (4.76 %) prescriptions (table 3).The most common combination prescribed in stage 1 hypertension was ARBs + BBs, while in stage 2 hypertension, it was ARBs + CCBs. The most frequently prescribed anti-hypertensive group either as monotherapy or in combination therapy was that of ARBs129(67.17 %) followed by BBs 99 (51.55%), CCBs 58 (30.2%), DUs 57 (29.65%), ACEIs 39 (20.3%) and ABs 1 (0.52 %) Figure-1 : Frequency of prescribing of antihypertensive category among monotherapy (figure 2). Analysis of frequency of prescribing pattern of individual anti-hypertensive drugs was also done. It was found that telmisartan was the most commonly prescribed 68 (35.41 %) and prazosin and cilnidipine were the least frequently prescribed anti-hypertensive agents 1 (0.52 %) (table 4). Around 62 (32.29 %) were on anti-platelet agents, 56 (29.16 %) were on anti-diabetics and 53 (27.60 %) were on hypolipidemics. Table 3. Frequency of prescribing of various combinations of anti-hypertensive drugs Table-1 : Distribution of males and females with respect to age ARBs: Angiotensin receptor blockers, CCBs: Calcium channel blockers, BBs: Beta blockers, DUs: Diuretics, ACEIs: Angiotensinconverting enzyme inhibitors, ABs: Alpha blockers 184
4 Dr. Hema Chhabra, et.al : Pattern of use of anti-hypertensive drugs Figure-2 : Overall frequency of prescribing according to category of anti-hypertensive drug Table-4 : Frequency of prescribing of individual anti-hypertensive drug 192 prescriptions of hypertensive patients were analyzed over a period of six months. Out of total 192 cases, 45 (23.4 %) received monotherapy, while 147 (76.6 %) received multidrug therapy of anti-hypertensive agents. Amruth et al showed comparable results where monotherapy was prescribed in % and multidrug therapy in % cases. 5 Among monotherapy, the decreasing order of prescribing was as follows: ARBs 27 (60 %), CCBs 11 (24.4 %), DUs 4 (8.9 %) and ACEIs 3 (6.7 %). Studies conducted by Tandon et al and Sikidar et al also reported ARBs to be the most commonly employed 6,7 anti-hypertensive agent as monotherapy. This is in contrast to studies by Arief M and Mishra et al where ACEIs and CCBs were the most prevalent 8,9 drugs among monotherapy respectively. Two-drug combination was the most prevalent. Similar results were obtained in the study by Agarwal et al where dual therapy was a part of % prescriptions.10 Among two-drug therapy, ARBs + CCBs was the most commonly prescribed combination 21 (14.28 %). Similar results were obtained by Eslampanah Z et al and Hasan et al.11,12 In contrast, studies done by Pavani et al and Sindhu et al reported ARBs + BBs and ARBs + DUs as the commonest dual therapies.13,14 Among three-drug therapy, ARBs + BBs + DUs was the most frequently prescribed 13 (8.84 %), while there was only one four-drug combination ARBs + BBs + CCBs + DUs in 7 (4.76 %) prescriptions. DISCUSSION: Drug utilization studies are a parameter to assess rationality/irrationality in drug usage. Evaluation of prescribing trends over time helps in improvement of appropriateness and quality of drug usage in clinical scenario. In the present study, In the present study, the most commonly prescribed anti-hypertensive group either as monotherapy or in combination therapy was that of ARBs129 (67.17 %) followed by BBs 99 (51.55 %), CCBs 58 (30.2 %), DUs 57 (29.65 %) ACEIs 39 (20.3 %) and ABs 1 (0.52 %). These results are comparable to the study done by Hussain et al, while Shukrala et al revealed that the overall prescribing frequency 185
5 Dr. Hema Chhabra, et.al : Pattern of use of anti-hypertensive drugs 15,16 was maximum for diuretics and ACEIs. However, telmisartan was the most commonly prescribed 68 (35.41 %) and prazosin and cilnidipine were the least frequently prescribed anti-hypertensive agents 1 (0.52 %) among individual anti-hypertensive agent prescribing analysis.pawah et al observed telmisartan to be the most frequently prescribed drug, while Agarwal et al found losartan as the most preferred drug by the 17,10 prescribing physicians. Time trends in prescription of anti-hypertensive agents have shown diverse changes over the last decade. ARBs have superseded other antihypertensive categories in the present scenario. Prescribing of ACEIs has also increased over the years. Beta blockers have taken a back seat as an anti-hypertensive monotherapy agent and are restricted to combination therapy only. Calcium channel blockers are preferred in the elderly population and in isolated systolic hypertension. Alpha blockers have role in severe hypertension and benign prostatic hyperplasia in elderly males. CONCLUSION: Prescription pattern studies are an important part of rational medical care. They provide a means to judge the current status of drug use in medical set ups and to evaluate whether they are in accordance with the standard updated recommendations and guidelines or not. In this study, ARBs were the most frequently prescribed anti-hypertensive category. Dual therapy was a part of majority of prescriptions ; ARBs + CCBs being the commonest combination. Combination therapy was thus the trend in the present study. However, still a lot of loopholes exist in the adequate management of hypertension. Goal of treatment must be focused on effective blood pressure control and prevention of cardiovascular and cerebrovascular events. REFERENCES: 1. Artham SM, Lavie CJ, Milani RV, Ventura HO. Cbesity and Hypertension, Heart Failure, and Coronary Heart Disease Risk Factor, Paradox, and Recommendations for Weight Loss. The Ochsner Journal 2009;9: Raised blood pressure. Global Health Observatory (GHO) data. World Health O r g a n i z a t i o n [ L a s t a c c e s s e d o n : 2 4 t h F e b ] A v a i l a b l e a t : ressure_prevalence_text/en/ 3. A global brief on Hypertension. Silent Killer, global public health crisis. World Health Day 2013.Geneva, Switzerland. [ L a s t a c c e s s e d o n ; 2 4 t h F e b 2017].Available at: brief hypertension.pdf 4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood P r e s s u r e ; t h e J N C report.jama.2003;289(19): Amruth RV, Gautam A, Ghimire S, Shashidhar G, Mahesh NM, Gyawali S. Prescribing pattern of antihypertensive drugs and cost analysis in a tertiary care teaching hospital. World Journal of Pharmacy and Pharmaceutical Sciences2015;4(5): Tandon VR, Sharma S, Mahajan S, Mahajan A, Khajuria V, Mahajan V et al. Antihypertensive drug prescription patterns, rationality, and adherence to Joint National 186
6 Dr. Hema Chhabra, et.al : Pattern of use of anti-hypertensive drugs Committee-7 hypertension treatment guidelines among Indian postmenopausal women..j Midlife health 2014 Apr- Jun;5(2): Sikidar P, Chakravarty P, Purkayastha A, Tigga R. A study on prescribing pattern of anti-hypertensives in adult patients attending in a tertiary care hospital of Assam, India.Int J Basic Clin Pharmacol Jun;5(3): Arief M, Harika B, Satyanarayana B, Pasha SW, Paladugu ND, Pasha SI et al. Evaluation of prescribing pattern of anti-hypertensive drugs in a tertiary care hospital. Acta Chim. Pharm. Indica 2013; 3(2): Mishra R, Kesarwani P, Keshari SS. Prescription pattern of anti-hypertensive drugs in a tertiary care teaching hospital.international Journal of Medical Science and Public Health 2017;6(4): Agarwal S, Sharma K.Study of prescribing trends of anti-hypertensive drugs in a hospital at Jaipur. Journal of Chemical and Pharmaceutical Research 2016;8(2): Eslampanah Z. Drug utilization evaluation of anti-hypertensive agents in a medical care hospital. International Journal of Pharmaceutical Sciences and Research 2016;7(2): Hasan MJ. Pattern of drugs prescribed for treatment of hypertensive patients: BangladeshAfrican Journal of Pharmacy and Pharmacology 2016;10(25): Pavani V, Cidda M, Krishna TR, Parmar MY, Nalini M. Study Of Prescribing Patterns Of Anti-hypertensive Drugs. IJPBS.2012;2(2): Sindhu PR, Reddy MS.Study of Prescriptive Patterns of Anti-hypertensive Drugs in South India. International Journal of Advancements in Research & Technology.2013;2(6): Hussain Z, Sana A, Mohammed S, Razzaq MA. Patterns of drug therapy among diabetic hypertensive patients with other complications. Int J Pharm Pharm Sci. 2014;6(6): Shukrala F, Gabriel T. Assessment of prescribing, dispensing and patient use pattern of anti-hypertensive drugs for patients attending outpatient department of Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia.Drug Design, Development and Therapy 2015;9: Pawah AK, Chandra KP. Prospective study of prescribing pattern in patients with T2DM and hypertension.sch. J. App. Med. Sci. Received on 01/03/2017, Revised on 25/03/2017, Accepted on 25/03/
Prescription Pattern of Anti-Hypertensive Drugs in Adherence to JNC- 7 Guidelines
American Journal of Pharmacology and Toxicology Original Research Paper Prescription Pattern of Anti-Hypertensive Drugs in Adherence to JNC- 7 Guidelines 1 Krishna Murti, 1 M. Arif Khan, 1 Akalanka Dey,
More informationInternational Journal of Advancements in Research & Technology, Volume 2, Issue 6, June-2013 ISSN
ISSN 2278-7763 295 Study of Prescriptive Patterns of Antihypertensive Drugs in South India Popuri Rupa Sindhu, Malladi Srinivas Reddy St. Peters Institute of Pharmaceutical Sciences, Hanamkonda, Warangal-506001,
More informationDRUG UTILIZATION EVALUATION OF ANTI-HYPERTENSIVE AGENTS IN A MEDICAL CARE HOSPITAL
Eslampanah, IJPSR, 20; Vol. 7(2): 82-87. E-ISSN: 0975-82; P-ISSN: 20-548 IJPSR (20), Vol. 7, Issue 2 (Research Article) Received on August, 205; received in revised form, November, 205; accepted, January,
More informationJMSCR Vol 06 Issue 05 Page May 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 71.58 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i5.29 Trends in Prescribing Pattern
More informationInt. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences
Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,
More informationOriginal Research Article. Rohini Gupta 1 *, Apoorva Malhotra 2, Pavan Malhotra 2. Sidhra, Jammu, Jammu and Kashmir, India
International Journal of Research in Medical Sciences Gupta R et al. Int J Res Med Sci. 2018 Jul;6(7):2380-2384 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20182821
More informationJournal of Advances in Medical and Pharmaceutical Sciences. 17(1): 1-9, 2018; Article no.jamps ISSN:
Journal of Advances in Medical and Pharmaceutical Sciences 7(): -9, 08; Article no.jamps.46 ISSN: 394- A Study to Assess and Evaluate Prescribing Patterns of Antihypertensive Drugs in Medicine Ward of
More informationAntihypertensive Drugs Prescribing Pattern in Patients Attending to Medicine Outpatient Department
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 9 Ver. XIV (September. 2016), PP 53-57 www.iosrjournals.org Antihypertensive Drugs Prescribing
More informationDEPARTMENT OF GENERAL MEDICINE WELCOMES
DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global
More informationLong-Term Care Updates
Long-Term Care Updates August 2015 By Darren Hein, PharmD Hypertension is a clinical condition in which the force of blood pushing on the arteries is higher than normal. This increases the risk for heart
More informationSTUDY OF DRUG UITLIZATION PATTERN OF ANTIHYPERTENSIVE DRUGS IN HYPERTENSIVE NEPHROPATHY IN A TERTIARY CARE TEACHING HOSPITAL, BAREILLY, U.P.
RESEARCH ARTICLE STUDY OF DRUG UITLIZATION PATTERN OF ANTIHYPERTENSIVE DRUGS IN HYPERTENSIVE NEPHROPATHY IN A TERTIARY CARE TEACHING HOSPITAL, BAREILLY, U.P. Anju Madhwar 1,*, Dharmender Gupta 2, Sujata
More informationReceived: / Revised: / Accepted: / Published:
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationHypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
More informationPrescribing Pattern of Antihypertensive Drugs in Hypertensive Patients in Tertiary Care Hospital
International Journal of MediPharm Research ISSN:2395-423X www.medipharmsai.com Vol.03, No.02, pp 259-263, 2017 Prescribing Pattern of Antihypertensive Drugs in Hypertensive Patients in Tertiary Care Hospital
More informationOriginal article: A Study of prescription pattern of antihypertensive drugs in a tertiary Care teaching hospital
Original article: A Study of prescription pattern of antihypertensive drugs in a tertiary Care teaching hospital Pyarelal Associate Professor, Department of Pharmacology, Mediciti Institute of Medical
More informationAndhra Pradesh, India Corresponding Author: Dr. S. Parveen *
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn:2278-3008, p-issn:2319-7676. Volume 12, Issue 6 Ver. II (Nov. Dec. 2017), PP 46-53 www.iosrjournals.org Efficacy And Tolerability Of
More informationLayered Approaches to Studying Drug Responses
Layered Approaches to Studying Drug Responses Brian B Hoffman, MD Chief of Medicine VA Boston Health Care System Professor of Medicine Harvard Medical School Conflict of Interest: US Federal Grant Funding
More informationJNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
More informationTarget Blood Pressure Attainment in Diabetic Hypertensive Patients: Need for more Diuretics? Waleed M. Sweileh, PhD
Target Blood Pressure Attainment in Diabetic Hypertensive Patients: Need for more Diuretics? Waleed M. Sweileh, PhD Associate Professor, Clinical Pharmacology Corresponding author Waleed M. Sweileh, PhD
More informationPrescribing Trend of Antihypertensive Drugs in Sri Ganganagar District: A Retrospective Study
53 Article Prescribing Trend of Antihypertensive Drugs in Sri Ganganagar District: A Retrospective Study Amarjeet Singh*, Sudeep Bhardwaj, Ashutosh Aggarwal Department of Pharmacology, Seth G. L. Bihani
More informationEFFICACY & SAFETY OF ORAL TRIPLE DRUG COMBINATION OF TELMISARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF NON-DIABETIC HYPERTENSION
EFFICACY & SAFETY OF ORAL TRIPLE DRUG COMBINATION OF TELMISARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF NON-DIABETIC HYPERTENSION Khemchandani D. 1 and * Arif A. Faruqui 2 1 Bairagarh,
More informationUse of Antihypertensive Medications in Patients with type -2 Diabetes in Ajman, UAE
Use of Antihypertensive Medications in Patients with type -2 Diabetes in Ajman, UAE ORIGINAL ARTICLE Mohammed Arifulla 1, Lisha Jenny John 1, Jayadevan Sreedharan 2, Jayakumary Muttappallymyalil 3, Jenny
More informationUpdate on Current Trends in Hypertension Management
Friday General Session Update on Current Trends in Hypertension Management Shawna Nesbitt, MD Associate Dean, Minority Student Affairs Associate Professor, Department of Internal Medicine Office of Student
More informationThe Hypertension Clinic is a part of the Internal Medicine
Original Article Hypertension Registry at the Bangkok Hospital Medical Center: The First 7 Months Experience OBJECTIVE: The Hypertension Registry at the Bangkok Hospital Medical Center was established
More informationDRUG USE EVALUATION OF ANTIHYPERTENSIVE DRUGS IN THE TERTIARY CARE HOSPITAL
Page6558 Indo American Journal of Pharmaceutical Research, 2016 ISSN NO: 2231-6876 DRUG USE EVALUATION OF ANTIHYPERTENSIVE DRUGS IN THE TERTIARY CARE HOSPITAL Kamal Pandey, Prithvi Bikram Thakur, K. RamKumar,
More information2017 High Blood Pressure Clinical Practice Guideline
2017 High Blood Pressure Clinical Practice Guideline Applying the Latest Hypertension Guideline to Your Practice Carmine D Amico, D.O., F.A.C.C. 2017 ACC / AHA / AAPA / ABC / ACPM / AGS / APhA / ASH /
More informationBy Prof. Khaled El-Rabat
What is The Optimum? By Prof. Khaled El-Rabat Professor of Cardiology - Benha Faculty of Medicine HT. Introduction Despite major worldwide efforts over recent decades directed at diagnosing and treating
More informationA Prospective Study on Prescribing Pattern and Utilization of Anti-Hypertensive Drugs in A Tertiary Care Teaching Hospital
Research Article A Prospective Study on Prescribing Pattern and Utilization of Anti-Hypertensive Drugs in A Tertiary Care Teaching Hospital G. Bathula*, S. Tippaluru, R. K. Palagiri Department of Pharmacy
More informationPrevalence, awareness of hypertension in rural areas of Kurnool
Original article: Prevalence, awareness of hypertension in rural areas of Kurnool Dr. Sudhakar Babu*, Dr.Aruna MS** *Associate Professor, Dept of Community Medicine, Vishwa Bharathi Medical College Kurnool,
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationClinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital
Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC
More informationHypertension (JNC-8)
Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint
More informationABSTRACT KEYWORDS: The prevalence of hypertension varies from percentages in all
85 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 6(6): November-December 2017 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND
More informationPrevalence and risk factors of hypertension, among adults residing in an urban area of North India
Available online at www.ijpab.com INTERNATIONAL JOURNAL OF PURE & APPLIED BIOSCIENCE ISSN: 2320 7051 Int. J. Pure App. Biosci. 3 (2): 338-344 (2015) Research Article Prevalence and risk factors of hypertension,
More informationManagement of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University
Management of Hypertension in special groups BY DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University AGENDA SPECIAL GROUPS SPECIFIC DRUDS FOR SPECIAL GROUPS TARGET BP FOR SPECIAL GROUPS:
More informationWhich antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017
Which antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017 The most important reason for treating hypertension in primary care is to prevent
More informationDISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.
JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I
More informationVolume 2 Number 2 (2011)
Review of Global Medicine and Healthcare Research Volume 2 Number 2 (211) Publisher: DRUNPP Managed by: IOMC Group Website: www.iomcworld.com/rgmhr/ Drug Utilization Pattern and Co-morbidtities Among Hypertensive
More informationHypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital
Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI
More informationAdherence to International Guidelines in the Management of Hypertension in a Tertiary Hospital in Nigeria
Tropical Journal of Pharmaceutical Research, June 2008; 7 (2): 945-952 Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria. All rights reserved. Research Article Available
More informationEgyptian Hypertension Guidelines
Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich
More informationHypertension Update Clinical Controversies Regarding Age and Race
Hypertension Update Clinical Controversies Regarding Age and Race Allison Helmer, PharmD, BCACP Assistant Clinical Professor Auburn University Harrison School of Pharmacy July 22, 2017 DISCLOSURE/CONFLICT
More informationFirst line treatment of primary hypertension
First line treatment of primary hypertension Dr. Vijaya Musini Assistant Professor, Dept. Anesthesiology, Pharmacology and Therapeutics Manager, Drug Assessment Working Group Therapeutics Initiative Editor,
More informationDRUG UTILIZATION PATTERNS OF ANTIHYPERTENSIVES IN VARIOUS WARDS IN A TERTIARY CARE HOSPITAL IN TAMILNADU
Original Article DRUG UTILIZATION PATTERNS OF ANTIHYPERTENSIVES IN VARIOUS WARDS IN A TERTIARY CARE HOSPITAL IN TAMILNADU V.Gowri 1, K.Punnagai, K.Vijaybabu 3, Dr.Darling Chellathai 4 1 Assistant Professor
More informationOutcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension
Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension Prof. Massimo Volpe, MD, FAHA, FESC, Chair of Cardiology, Department of Clinical and Molecular Medicine
More informationAn Assessment of Antihypertensive Drug Utilization Patterns and Adherence to JNC-7 Guidelines in South Indian Tertiary Care Teaching Hospital
Research Article An Assessment of Antihypertensive Drug Utilization Patterns and Adherence to JNC-7 Guidelines in South Indian Tertiary Care Teaching Hospital Sai Sujana Surapaneni 1, Shaik Nasrin Arifa
More informationRole of Pharmacoepidemiology in Drug Evaluation
Role of Pharmacoepidemiology in Drug Evaluation Martin Wong MD, MPH School of Public Health and Primary Care Faculty of Medicine Chinese University of Hog Kong Outline of Content Introduction: what is
More informationInternational Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: Vol.8, No.8, pp , 2015
International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: 0974-4304 Vol.8, No.8, pp 131-135, 2015 Assessment of Hypertension ledge Among Pharmacists in Medan City, North Sumatera Khairunnisa*,
More informationHypertension in the South-East Asia Region: an overview
Hypertension in the South-East Asia Region: an overview Anand Krishnan i, Renu Garg ii and Athula Kahandaliyanage iii Abstract Raised blood pressure or hypertension is the single most important risk factor
More informationJMSCR Vol 05 Issue 07 Page July 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i7.90 Original Research Article Prevalence of
More informationRajashree Samal*, Jyoti Prakash Panda, Kali Prasad Pattnaik
International Journal of Research in Medical Sciences Samal R et al. Int J Res Med Sci. 2017 Jul;5(7):2931-2937 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20172537
More information47 Hypertension in Elderly
47 Hypertension in Elderly YOU DO NOT HEAL OLD AGE; YOU PROTECT IT; YOU PROMOTE IT; YOU EXTEND IT Sir James Sterling Ross Abstract: The prevalence of hypertension rises with age and the complications secondary
More informationSTANDARD treatment algorithm mmHg
STANDARD treatment algorithm 130-140mmHg (i) At BASELINE, If AVERAGE SBP 1 > 140mmHg If on no antihypertensive drugs: Start 1 drug: If >55 years old / Afro-Caribbean: Calcium channel blocker (CCB) 2 If
More informationHYPERTENSION GUIDELINES WHERE ARE WE IN 2014
HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University
More informationLessons learned from AASK (African-American Study of Kidney Disease and Hypertension)
Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension) Janice P. Lea, MD, MSc, FASN Professor of Medicine Chief Medical Director of Emory Dialysis ASH Clinical Specialist
More informationText-based Document. Women are Different!: Gender Specific Protocols for Treatment of Hypertension. Authors Whiffen, Rebecca J.
The Henderson Repository is a free resource of the Honor Society of Nursing, Sigma Theta Tau International. It is dedicated to the dissemination of nursing research, researchrelated, and evidence-based
More informationJNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH
JNC 8 -Controversies Sagren Naidoo Nephrologist CMJAH Joint National Committee (JNC) Panel appointed by the National Heart, Lung, and Blood Institute (NHLBI) First guidelines (JNC-1) published in 1977
More informationCedars Sinai Diabetes. Michael A. Weber
Cedars Sinai Diabetes Michael A. Weber Speaker Disclosures I disclose that I am a Consultant for: Ablative Solutions, Boston Scientific, Boehringer Ingelheim, Eli Lilly, Forest, Medtronics, Novartis, ReCor
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
Anand IS,, 2014; Volume 3(3): 178-187 INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE EFFECT OF NEBIVOLOL AND METOPROLOL ON PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS ANAND IS, PATEL
More informationEvolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH)
Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH) Sidney C. Smith, Jr. MD, FACC, FAHA, FESC Professor of Medicine/Cardiology University of North Carolina
More informationHypertension JNC 8 (2014)
Hypertension JNC 8 (2014) Renewed: February 2018 Updated: February 2015 Comparison of Seventh Joint National Committee (JNC 7) vs. Eighth Joint National Committee (JNC 8) Hypertension Guidelines Methodology
More informationHypertension Guidelines 2017
Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,
More informationWhat s In the New Hypertension Guidelines?
American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the
More informationHypertension Update 2016 AREEF ISHANI, MD MS CHIEF OF MEDICINE MINNEAPOLIS VA MEDICAL CENTER PROFESSOR OF MEDICINE UNIVERSITY OF MINNESOTA
Hypertension Update 2016 AREEF ISHANI, MD MS CHIEF OF MEDICINE MINNEAPOLIS VA MEDICAL CENTER PROFESSOR OF MEDICINE UNIVERSITY OF MINNESOTA Case 1 What should be your BP goal for an elderly (> 75 yrs of
More informationHypertension Update Background
Hypertension Update Background Overview Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Management Guideline Comparison
More informationManagement of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine
Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing
More informationSee Related Commentary on Page 487.
Blood Pressure Control and Pharmacotherapy Patterns in the United States Before and After the Release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood
More informationAre hypertensive elderly patients treated differently?
ORIGINAL RESEARCH Are hypertensive elderly patients treated differently? Amy DG Huebschmann 1 Caroline Bublitz 2 Robert J Anderson 1 1 University of Colorado-Denver Health Sciences Center (UCDHSC), Department
More informationThe JNC 8 Guidelines: A Clinical Review
8 Osteopathic Family Physician (2015)1, 8-12 Osteopathic Family Physician, Volume 7, No. 1, January/February 2015 The JNC 8 Guidelines: A Clinical Review Gary Rivard, DO; Erik Seth Kramer, DO, MPH; Sean
More informationHypertension Update. Aaron J. Friedberg, MD
Hypertension Update Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Background Diagnosis Management Overview Guideline
More informationObjectives. Describe results and implications of recent landmark hypertension trials
Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships
More informationBlood Pressure Lowering Efficacy of Perindopril/ Indapamide Fixed Dose Combination in Uncontrolled Hypertension
525 Blood Pressure Lowering Efficacy of Perindopril/ Indapamide Fixed Dose Combination in Uncontrolled Hypertension PHIMDA Kriangsak 1* and CHOTNOPARATPAT Paiboon 2 1 Diabetes and Hypertension Clinic,
More informationALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic
1 U.S. Department of Health and Human Services National Institutes of Health Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker
More informationJared Moore, MD, FACP
Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner
More informationHypertension Pharmacotherapy: A Practical Approach
Hypertension Pharmacotherapy: A Practical Approach Ronald Victor, MD Burns & Allen Chair in Cardiology Director, The Hypertension Center Associate Director, The Heart Institute Hypertension Center 1. 2.
More informationIJRPC 2011, 1(3) Patel et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article EVALUATION OF COMPLIANCE AND BLOOD PRESSURE REDUCTION IN PATIENTS TREATED WITH AMLODIPINE
More informationHypertension is among the most prevalent chronic
Switching Between Different ARBs in Patients With Controlled BP At a Glance Practical Implications e82 Author Information e86 Web Exclusive Original Research Khalid M. Kamal, PhD; Christopher Zacker, RPh,
More informationCombination Therapy for Hypertension
Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP
More informationhypertension Head of prevention and control of CVD disease office Ministry of heath
hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension
More informationThiazide or Thiazide Like? Choosing Wisely Academic Detailing Conference Digby Pines October 12-14
Thiazide or Thiazide Like? Choosing Wisely Academic Detailing Conference Digby Pines October 12-14 Disclosures Pam McLean-Veysey, Team Leader Drug Evaluation Unit DEU funded by the Drug Evaluation Alliance
More informationEffectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/Amlodipine
831 Original Article Hypertens Res Vol.3 (27) No.9 p.831-837 Effectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/Amlodipine
More informationPrevention of Heart Failure: What s New with Hypertension
Prevention of Heart Failure: What s New with Hypertension Ali AlMasood Prince Sultan Cardiac Center Riyadh 3ed Saudi Heart Failure conference, Jeddah, 13 December 2014 Background 20-30% of Saudi adults
More informationNone. Disclosure: Relationships with Industry Conflicts of Interests. Learning Objectives: Participants will be able to:
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) James W. Shaw, MD Memorial Lecture
More informationHypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS
Hypertension and the Challenge of Adherence Geneva Clark Briggs, Pharm.D., BCPS Outline Brief overview of HTN and pharmacologic therapies Role of pharmacists in collaboration with patients and physicians
More informationHypertension Update 2009
Hypertension Update 2009 New Drugs, New Goals, New Approaches, New Lessons from Clinical Trials Timothy C Fagan, MD, FACP Professor Emeritus University of Arizona New Drugs Direct Renin Inhibitors Endothelin
More informationEvaluation of Drug Information Service provided by Clinical Pharmacy Department based on Provider and Enquirers' Perspective
APTI ijopp Evaluation of Drug Information Service provided by Clinical Pharmacy Department based on Provider and Enquirers' Perspective 1 2 3 Kuchake V.G, Maheshwari O.D, Surana S.J, 4 5 Patil P.H, Dighore
More informationManagement of High Blood Pressure in Adults
Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) James, P. A. (2014, February 05). 2014 Guideline for Management
More informationManaging Hypertension in 2016
Managing Hypertension in 2016: Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu
More informationChapman University Digital Commons. Chapman University. Michael S. Kelly Chapman University,
Chapman University Chapman University Digital Commons Pharmacy Faculty Articles and Research School of Pharmacy 12-30-2016 Assessment of Achieved Systolic Blood Pressure in Newly Treated Hypertensive Patients
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationDon t let the pressure get to you:
Balanced information for better care Don t let the pressure get to you: Current evidence-based goals for treating hypertension A cornerstone of primary care: Lowering high blood pressure prevents cardiovascular
More informationPre-ALLHAT Drug Use. Diuretics. ß-Blockers. ACE Inhibitors. CCBs. Year. % of Treated Patients on Medication. CCBs. Beta Blockers.
Pre- Drug Use % of Treated Patients on Medication 60 50 40 30 20 10 0 1978 Diuretics ß-Blockers ACE Inhibitors Year CCBs CCBs Beta Blockers Diuretics ACE Inhibitors 1980 1982 1984 1986 1988 1990 1992 IMS
More informationHTN talk_l Davis_ /28/2018
1 2 GUIDELINES PUBLISHED AHEAD OF PRINT NOV 13, 2017 = SAME DAY AS PUBLIC PRESENTATION LESLIE L DAVIS, PHD, RN, ANP-BC, FPCNA, FAANP, FAHA The New Guidelines Have Been Published! Whelton PK, Carey RM,
More informationAbbreviations Cardiology I
Cardiology I and Clinical Controversies Joseph J. Saseen, Pharm.D., FCCP, BCPS (AQ Cardiology) Reviewed by Stuart T. Haines, Pharm.D., FCCP, BCPS; and Michelle M. Richardson, Pharm.D., FCCP, BCPS Learning
More informationPatient persistence with antihypertensive drugs in France, Germany and the UK
Patient persistence with antihypertensive drugs in France, Germany and the UK B. Ehlken (1), K. Kostev (1), A. Sandberg (2), B. Holz (1), A. M. S. Oberdiek (2) (1) IMS Health Frankfurt / Munich, Germany
More informationHypertension and Cardiovascular Disease
Hypertension and Cardiovascular Disease Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic,
More informationTreating Hypertension in Individuals with Diabetes
Treating Hypertension in Individuals with Diabetes Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any
More informationApproximately 73.6 million adults in the United States have
n clinical n Hypertension Treatment and Control Within an Independent Nurse Practitioner Setting Wendy L. Wright, MS; Joan E. Romboli, MSN; Margaret A. DiTulio, MS, MBA; Jenifer Wogen, MS; and Daniel A.
More informationC h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario
C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario M Paul Anand Consultant Physician, Lady Ratan Tata Medical Centre, M. Karve Road, Cooperage, Mumbai Executive Editor, API Textbook of Medicine Introduction
More informationMODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk
MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu
More information